Home » Drug Warnings » FDA Revokes Approval of Avastin for Treatment of Breast Cancer

FDA Revokes Approval of Avastin for Treatment of Breast Cancer

"photo of Avastin"On November 18, 2011, the FDA revoked its approval of  Avastin (bevacizumab) for the treatment of metastatic breast cancer. According to FDA Commissioner Margaret Hamburg, MD, evidence shows that the risks associated with this medication outweigh the possible benefits. Although early studies were encouraging, follow-up studies fail to support these findings and clearly demonstrate the potentially life-threatening side effects of Avastin. These side effects include severe hypertension, hemorrhage, and perforations of the stomach, nose and intestines.

Avastin retains FDA approval for the treatment of colon, kidney, lung and brain cancer. Furthermore, doctors may continue to prescribe Avastin off-label for the treatment of breast cancer, and Medicare has stated it will continue to cover the cost of the medication.

Click here for the FDA Statement revoking approval

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s